The results of the current study support the hypothesis that MAPs abnormalities in Tsc2+/− mice are the result of the neurotoxic effects of mTOR up-stimulation rather than the reason that actively contributes to the pathology of TSC-related disorders. This evidence concerns the gene C3orf62 and tuberous sclerosis.